First-line treatments for advanced hepatocellular carcinoma: a network meta-analysis and cost-effectiveness analysis in China and the United States.

Ke-Xin SunShan-Shan CaoFeng-Hao ShiYue GuanMeng TangMei-Na ZhaoYu-Fan JianBin CuiZhi-Yan LiJing-Wen WangFeng YuYi Ding

Published in: Therapeutic advances in gastroenterology (2022)

This study has been registered on the PROSPERO database with the registration number CRD42021286575.

Keyphrases